Literature DB >> 15701989

Burkitt lymphoma and Williams syndrome: a model for children with a multisystem disorder and malignancy.

Courtney D Thornburg1, Diane Roulston, Valerie P Castle.   

Abstract

The authors describe a child with Williams syndrome who developed Burkitt lymphoma with a t(8;14). Williams syndrome is a contiguous gene syndrome that is not associated with a predilection for cancer. However, the management of a child with Williams syndrome and a malignancy is complicated by underlying disease in multiple organs. In 2001, the American Academy of Pediatrics published health care guidelines for children with Williams syndrome. These guidelines were adopted in the treatment of this child. Disease-specific guidelines should be applied to other children with multisystem disorders such as Down syndrome that require treatment of a malignancy.

Entities:  

Mesh:

Year:  2005        PMID: 15701989     DOI: 10.1097/01.mph.0000153444.43816.ea

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

1.  Late onset cerebellar metastasis from oesophageal adenocarcinoma in Williams Syndrome.

Authors:  Nicola Montano; Pasquale De Bonis; Libero Lauriola; Fabio Papacci; Corrado Lucantoni; Cesare Colosimo; Beatrice Cioni; Mario Meglio
Journal:  J Neurooncol       Date:  2008-04-08       Impact factor: 4.130

2.  Pilomyxoid astrocytoma of the cerebellum with Williams syndrome: a case report.

Authors:  Masashi Chonan; Masayuki Kanamori; Toshihiro Kumabe; Ryuta Saito; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2013-04-20       Impact factor: 1.475

3.  Bilateral burkitt lymphoma of the ovaries: a report of a case in a child with williams syndrome.

Authors:  Grace Ifeyinwa Onimoe; Samir Kahwash; Amanda Termuhlen; Thomas G Gross; Elizabeth Varga; Melissa J Rose
Journal:  Case Rep Med       Date:  2011-05-26

4.  Constitutional and somatic deletions of the Williams-Beuren syndrome critical region in non-Hodgkin lymphoma.

Authors:  David Guenat; Samuel Quentin; Carmelo Rizzari; Catarina Lundin; Tiziana Coliva; Patrick Edery; Helen Fryssira; Laurent Bermont; Christophe Ferrand; Jean Soulier; Christophe Borg; Pierre-Simon Rohrlich
Journal:  J Hematol Oncol       Date:  2014-11-07       Impact factor: 17.388

5.  The Tumor Suppressor BCL7B Functions in the Wnt Signaling Pathway.

Authors:  Tomoko Uehara; Eriko Kage-Nakadai; Sawako Yoshina; Rieko Imae; Shohei Mitani
Journal:  PLoS Genet       Date:  2015-01-08       Impact factor: 5.917

6.  Williams-Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma.

Authors:  Ryo Kimura; Yuko Ishii; Kiyotaka Tomiwa; Tomonari Awaya; Masatoshi Nakata; Takeo Kato; Shin Okazaki; Toshio Heike; Masatoshi Hagiwara
Journal:  Front Genet       Date:  2018-09-04       Impact factor: 4.599

7.  Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling.

Authors:  Mark O'Driscoll; William B Dobyns; Johanna M van Hagen; Penny A Jeggo
Journal:  Am J Hum Genet       Date:  2007-05-17       Impact factor: 11.025

8.  Haploinsufficiency of DNA Damage Response Genes and their Potential Influence in Human Genomic Disorders.

Authors:  Mark O'Driscoll
Journal:  Curr Genomics       Date:  2008-05       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.